Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shenzhen Zesum Technology
301486
5
Henan Shijia Photons Technology
688313
CN Stock MarketDetailed Quotes
301108 Tongling Jieya Biologic Technology
- 27.17
- -0.32-1.16%
Trading Apr 25 13:59 CST
2.18BMarket Cap140.05P/E (TTM)
28.46High26.94Low24.51KlotVolume27.55Open27.49Pre Close67.91MTurnover7.12%Turnover Ratio112.27P/E (Static)80.40MShares32.2352wk High1.19P/B935.35MFloat Cap20.8152wk Low32.99Limit Up34.43MShs Float95.97Historical High21.99Limit Down5.53%Amplitude20.81Historical Low0.36Dividend TTM27.71Avg Price11.68KlotAsk1.32%Div YieldTTM100Lot Size11.27KlotBid
Tongling Jieya Biologic Technology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 12.72%802.65M | -39.29%403.81M | 1.32%343.21M | 74.10%632.22M | -8.19%712.08M | -33.79%665.16M | -72.07%338.73M | -69.42%363.13M | -39.79%775.57M | -29.03%1B |
| Transactional financial assets | 49.56%441.04M | 60.62%659.33M | 64.40%692.52M | -35.50%282.58M | -33.78%294.9M | 36.55%410.49M | 20.30%421.25M | 45.99%438.12M | 77.44%445.3M | --300.62M |
| Notes receivable and accounts receivable | 2.04%126.47M | -20.55%135.76M | -8.03%137.57M | -8.31%143.65M | 2.67%123.94M | 22.93%170.88M | -2.18%149.58M | -11.70%156.67M | 4.77%120.72M | -14.18%139.01M |
| -Notes receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --50K | ---- |
| -Accounts receivable | 2.04%126.47M | -20.55%135.76M | -8.03%137.57M | -8.31%143.65M | 2.71%123.94M | 22.93%170.88M | -2.18%149.58M | -11.70%156.67M | 4.73%120.67M | -14.18%139.01M |
| Other receivables (including interest and dividends) | -11.42%1.9M | -28.52%591.84K | 31.86%1.13M | 41.71%941.46K | 223.48%2.15M | 25.62%827.98K | 22.38%859.76K | -2.73%664.36K | 14.86%663.51K | 57.69%659.14K |
| -Other receivable | ---- | ---- | ---- | 41.71%941.46K | ---- | 25.62%827.98K | ---- | -2.73%664.36K | ---- | 57.69%659.14K |
| Advance payment | 175.69%14.37M | 64.47%5.39M | 86.38%5.34M | -16.38%4.47M | 37.18%5.21M | 3.98%3.28M | 21.02%2.87M | 13.95%5.35M | -46.17%3.8M | -42.59%3.15M |
| Inventories | 10.51%79.93M | 11.99%77.19M | -5.44%74.47M | 5.76%66.05M | 18.59%72.33M | 7.40%68.93M | -12.97%78.76M | -38.01%62.45M | -48.09%60.99M | -55.01%64.18M |
| Non-current assets due within one year | -22.16%186.4M | 45.16%268.23M | 45.20%266.12M | 1,251.18%370.09M | --239.46M | --184.78M | --183.29M | --27.39M | ---- | ---- |
| Other current assets | -98.68%2.15M | 106.02%171.43M | -46.03%218.79M | -49.84%191.48M | 9,942.80%162.94M | 2,461.08%83.21M | 10,201.59%405.43M | 22,809.33%381.77M | -56.23%1.62M | -78.89%3.25M |
| Total current assets | 2.60%1.65B | 8.45%1.72B | 10.04%1.74B | 17.83%1.69B | 14.51%1.61B | 4.76%1.59B | -12.82%1.58B | -19.02%1.44B | -21.07%1.41B | -13.04%1.52B |
| Non Current assets | ||||||||||
| Debt investment | ---- | ---- | ---- | -85.14%53.27M | -61.11%148.84M | -18.59%228.37M | --226.52M | --358.5M | --382.75M | --280.52M |
| Other non-current financial assets | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Investment real estate | ---- | -5.44%3.49M | --3.54M | --3.59M | --3.64M | --3.69M | ---- | ---- | ---- | ---- |
| Long-term equity investment | -46.90%13.17M | -8.21%14.43M | 60.83%22.76M | --25.24M | --24.79M | --15.72M | --14.15M | ---- | ---- | ---- |
| Fixed assets | ---- | ---- | ---- | 23.40%248.8M | ---- | 13.82%241.99M | ---- | -11.09%201.63M | ---- | -11.04%212.6M |
| Constru in process | ---- | ---- | ---- | 503.89%67.8M | ---- | -7.46%4.1M | ---- | 87.28%11.23M | ---- | -35.39%4.43M |
| Intangible assets | 18.21%41.72M | -2.34%34.45M | -2.24%34.73M | 22.96%35.01M | 24.27%35.29M | 23.15%35.28M | 22.96%35.53M | -2.29%28.48M | -3.36%28.4M | -2.62%28.65M |
| Long deferred expense | 45.95%2.46M | 49.44%2.79M | --2.65M | --1.89M | --1.68M | --1.87M | ---- | ---- | ---- | ---- |
| Usufruct assets | -49.82%7.81M | -44.19%9.83M | -30.07%11.49M | -27.11%13.53M | -23.58%15.56M | -7.11%17.6M | -41.45%16.43M | -35.72%18.56M | -31.39%20.37M | -37.87%18.95M |
| Other non current assets | 4.84%27.23M | -65.63%4.33M | -57.22%3.96M | -50.40%2.57M | 1,316.52%25.98M | 100.78%12.61M | 745.34%9.26M | 250.13%5.18M | 139.34%1.83M | 1,820.20%6.28M |
| Total non current assets | -18.09%426.49M | -36.05%358.93M | -27.55%389.9M | -27.56%451.7M | -19.98%520.7M | 1.78%561.23M | 82.31%538.16M | 109.32%623.57M | 114.72%650.7M | 77.96%551.43M |
| Total assets | -2.45%2.08B | -3.17%2.08B | 0.49%2.13B | 4.08%2.14B | 3.61%2.13B | 3.96%2.15B | 0.50%2.12B | -0.56%2.06B | -1.36%2.06B | 0.70%2.07B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Notes payable and accounts payable | -2.98%184.02M | -10.75%187.82M | 5.21%211.9M | 29.91%226.16M | 25.22%189.68M | 17.20%210.43M | 2.76%201.41M | -6.58%174.09M | -24.90%151.47M | -28.67%179.56M |
| -Notes payable | -21.61%67.46M | -17.78%71.38M | -3.07%69.53M | 36.22%76.39M | 22.66%86.05M | -2.10%86.81M | -16.78%71.73M | -28.86%56.08M | -16.85%70.16M | -25.32%88.68M |
| -Accounts payable | 12.48%116.56M | -5.81%116.44M | 9.78%142.37M | 26.91%149.77M | 27.44%103.63M | 36.03%123.62M | 18.09%129.68M | 9.76%118.01M | -30.70%81.32M | -31.66%90.88M |
| Contract liabilities | -30.58%2.49M | 155.64%3.7M | -22.52%1.91M | -81.75%934.25K | 415.70%3.59M | -94.91%1.45M | -94.86%2.47M | -92.12%5.12M | -98.62%696.52K | 153.01%28.39M |
| Salaries payable | -1.54%6.6M | -18.06%8.83M | -24.85%8.48M | -19.64%7.25M | 3.62%6.7M | 21.40%10.77M | 32.33%11.28M | 23.01%9.02M | 4.67%6.47M | -15.20%8.87M |
| Taxs payable | -46.21%2.05M | -75.44%2.16M | 16.40%4.67M | 126.75%4.97M | -52.85%3.81M | 100.75%8.78M | -59.59%4.01M | -78.32%2.19M | 6.56%8.09M | -48.42%4.37M |
| Other payable (including interest and dividends) | 166.54%831.06K | 337.52%2.25M | -51.44%527.84K | -18.03%475.45K | -82.08%311.79K | -65.69%513.23K | 1,570.08%1.09M | 791.16%580K | 2,572.79%1.74M | -63.09%1.5M |
| -Other payable | ---- | ---- | ---- | -18.03%475.45K | ---- | -65.69%513.23K | ---- | 791.16%580K | ---- | -63.09%1.5M |
| Non current liabilities due within one year | 13.50%7.58M | -9.39%7.49M | 61.37%10.42M | 29.29%8.45M | -52.05%6.68M | -38.26%8.26M | -25.17%6.46M | -13.37%6.53M | 116.03%13.93M | 149.91%13.39M |
| Other current liabilities | -33.53%300.83K | 183.44%470.24K | 435.98%239K | 33.75%98.14K | 694.63%452.55K | 49.95%165.9K | 282.31%44.59K | 2,254.67%73.38K | -14.16%56.95K | 5.78%110.64K |
| Total current liabilities | -3.66%203.88M | -12.08%212.7M | 4.08%238.15M | 24.95%248.86M | 15.70%211.62M | 2.43%241.92M | -16.58%228.81M | -28.22%199.17M | -32.89%182.9M | -18.95%236.18M |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 4.36%5.86M | 4.41%5.8M | 4.46%5.74M |
| Long term account payable | ---- | ---- | ---- | --3.1M | ---- | --1M | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | 21.01%20.59M | 21.31%21.52M | 1.90%17.78M | 5.63%18.29M | -2.18%17.02M | 20.36%17.74M | -6.53%17.45M | -7.24%17.32M | -10.86%17.39M | -19.45%14.74M |
| Long term deferred income | -16.45%15.54M | -18.16%15.97M | -19.16%16.84M | 7.90%17.71M | 10.26%18.6M | 6.59%19.51M | 9.33%20.83M | -15.65%16.42M | -19.02%16.87M | 23.64%18.3M |
| Lease liabilities | -87.72%1.18M | -87.72%1.18M | -62.10%3.42M | -40.20%5.43M | -38.37%9.65M | -24.42%9.65M | -66.68%9.02M | -67.27%9.08M | -44.94%15.66M | -56.14%12.77M |
| Total non current liabilities | -16.57%39.52M | -14.61%40.9M | -13.02%41.14M | -8.50%44.54M | -14.99%47.37M | -7.08%47.9M | -32.87%47.29M | -31.92%48.68M | -25.04%55.72M | -23.87%51.55M |
| Total liabilities | -6.02%243.4M | -12.50%253.6M | 1.15%279.29M | 18.38%293.4M | 8.53%258.98M | 0.73%289.82M | -19.91%276.1M | -28.98%247.85M | -31.21%238.63M | -19.87%287.73M |
| Shareholders equity | ||||||||||
| Paid-in capital | -1.00%80.4M | 0.00%81.21M | 0.00%81.21M | 0.00%81.21M | 0.00%81.21M | 0.00%81.21M | 0.00%81.21M | 0.00%81.21M | 0.00%81.21M | 0.00%81.21M |
| Capital reserve funds | -2.15%1B | -0.18%1.02B | 0.03%1.03B | 0.19%1.03B | 0.34%1.03B | 0.48%1.02B | 1.35%1.03B | 1.23%1.03B | 0.89%1.02B | 0.56%1.02B |
| Surplus reserve funds | 0.00%66.73M | 0.00%66.73M | 0.00%66.73M | 0.00%66.73M | 0.00%66.73M | 0.00%66.73M | 0.00%66.73M | 0.00%66.73M | 0.00%66.73M | 0.00%66.73M |
| Retained profit | -1.93%687.21M | -1.41%677.14M | 4.08%692.36M | 7.46%684.27M | 7.89%700.74M | 12.18%686.84M | 10.83%665.22M | 13.62%636.75M | 12.06%649.52M | 15.04%612.25M |
| Less:Treasury stock | ---- | --20.06M | --20.05M | --10.32M | ---- | ---- | ---- | ---- | ---- | ---- |
| Shareholders equity without minority interests | -1.94%1.84B | -1.70%1.83B | 0.40%1.85B | 2.16%1.85B | 3.00%1.87B | 4.47%1.86B | 4.47%1.84B | 5.15%1.81B | 4.53%1.82B | 5.06%1.78B |
| Minority interests | -99.72%778.45 | -95.53%13.58K | -45.32%189K | -74.96%213.04K | -71.15%274.77K | --304.1K | --345.64K | --850.67K | --952.3K | ---- |
| Total shareholder equity | -1.96%1.84B | -1.72%1.83B | 0.39%1.85B | 2.13%1.85B | 2.97%1.87B | 4.49%1.86B | 4.48%1.84B | 5.20%1.81B | 4.59%1.82B | 5.06%1.78B |
| Total liabilityies and equity | -2.45%2.08B | -3.17%2.08B | 0.49%2.13B | 4.08%2.14B | 3.61%2.13B | 3.96%2.15B | 0.50%2.12B | -0.56%2.06B | -1.36%2.06B | 0.70%2.07B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs